Thomas Kochy is Adverum’s vice president, commercial and program strategy, leading commercial planning, product strategy, and program management. Mr. Kochy has over 15 years of experience in the biopharmaceutical industry. Prior to joining Adverum, Mr. Kochy served as a strategy consultant in ocular disease. Prior to that, he worked at Genentech from 2004 to 2019, most recently as regional sales director for Actemra and Rituxan Immunology. Earlier in his career at Genentech, he led the ophthalmology pipeline strategy team and worked on Lucentis, leading various marketing functions through the wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) launches. Mr. Kochy also led the Lucentis lifecycle team through key early decisions in development of the Port Delivery System. He began his career in ophthalmology market planning creating business cases that led to the expansion of Lucentis development plans into DME and RVO. Mr. Kochy holds a Master of Business Administration from the University of California, Berkeley and a Bachelor of Science in Mechanical Engineering from the University of California, Los Angeles.